Amgen scoops up Onyx for $10.4 bln (1:03)
Aug. 26 - Amgen looks to plug holes in its drug pipeline with finally reaching a deal to acquire Onyx Pharmaceuticals for $10.4 billion. Conway G. Gittens reports. ( Transcript )
Hard-edged reporting, insight and analysis, Reuters TV breaks ground creating informative news and financial videos. Showcasing Reuters’ 3000 award-winning journalists, Reuters TV delivers high-energy investigative journalism with concise explanations. Check it out and let us know what you think.